Business Description
TransMedics Group Inc
NAICS : 334510
SIC : 3845
ISIN : US89377M1099
Description
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.9 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.35 | |||||
| Debt-to-EBITDA | -3.35 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 13.72 | |||||
| Beneish M-Score | -0.23 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 23.9 | |||||
| 3-Year EBITDA Growth Rate | 20.7 | |||||
| 3-Year EPS without NRI Growth Rate | 19.5 | |||||
| 3-Year FCF Growth Rate | 5.1 | |||||
| 3-Year Book Growth Rate | 31.2 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.19 | |||||
| 9-Day RSI | 45.11 | |||||
| 14-Day RSI | 45.99 | |||||
| 6-1 Month Momentum % | 27.85 | |||||
| 12-1 Month Momentum % | 164.64 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.14 | |||||
| Quick Ratio | 8.3 | |||||
| Cash Ratio | 6.82 | |||||
| Days Inventory | 190.99 | |||||
| Days Sales Outstanding | 69.22 | |||||
| Days Payable | 38.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -14.9 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 68.78 | |||||
| Operating Margin % | -20.28 | |||||
| Net Margin % | -23.76 | |||||
| ROE % | -20.85 | |||||
| ROA % | -13.1 | |||||
| ROIC % | -50.13 | |||||
| ROC (Joel Greenblatt) % | -51.41 | |||||
| ROCE % | -12.64 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 18.94 | |||||
| PB Ratio | 12.27 | |||||
| Price-to-Tangible-Book | 12.27 | |||||
| EV-to-EBIT | -91.34 | |||||
| EV-to-EBITDA | -110.67 | |||||
| EV-to-Revenue | 18.69 | |||||
| EV-to-Forward-Revenue | 12.25 | |||||
| EV-to-FCF | -47.42 | |||||
| Price-to-Net-Current-Asset-Value | 14.14 | |||||
| Price-to-Net-Cash | 23.44 | |||||
| Earnings Yield (Greenblatt) % | -1.09 |
Balance Sheet Breakdown
Cashflow Statement Breakdown
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TMDX
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
TransMedics Group Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 119.133 | ||
| EPS (TTM) ($) | -0.95 | ||
| Beta | 1.04 | ||
| Volatility % | 61.07 | ||
| 14-Day RSI | 45.99 | ||
| 14-Day ATR ($) | 3.464775 | ||
| 20-Day SMA ($) | 73.72675 | ||
| 12-1 Month Momentum % | 164.64 | ||
| 52-Week Range ($) | 24.01 - 90.15 | ||
| Shares Outstanding (Mil) | 32.55 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
TransMedics Group Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
TransMedics Group Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
TransMedics Group Inc Frequently Asked Questions
What is TransMedics Group Inc(TMDX)'s stock price today?
The current price of TMDX is $72.66. The 52 week high of TMDX is $90.15 and 52 week low is $24.01.
When is next earnings date of TransMedics Group Inc(TMDX)?
The next earnings date of TransMedics Group Inc(TMDX) is 2023-08-01 Est..
Does TransMedics Group Inc(TMDX) pay dividends? If so, how much?
TransMedics Group Inc(TMDX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
